AYR WELLNESS INC.RES.VTG.
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods in United States. The company engages in the possession, manufacture, use, sale, or distribution of cannabis and/or holding of licenses in the adult-use and/or medicinal cannabis marketplace. Its portfolio includes consumer-packaged goods under the kynd, HAZE, and Later Days brand names, … Read more
AYR WELLNESS INC.RES.VTG. (3KJB) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, AYR WELLNESS INC.RES.VTG. (3KJB) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
AYR WELLNESS INC.RES.VTG. - Net Assets Trend (None–None)
This chart illustrates how AYR WELLNESS INC.RES.VTG.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AYR WELLNESS INC.RES.VTG. (None–None)
The table below shows the annual net assets of AYR WELLNESS INC.RES.VTG. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to AYR WELLNESS INC.RES.VTG.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
AYR WELLNESS INC.RES.VTG. Competitors by Market Cap
The table below lists competitors of AYR WELLNESS INC.RES.VTG. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Volt Carbon Technologies Inc
V:VCT
|
$3.60 Million |
|
PROSPECT RIDGE RESOURCES
F:0ED
|
$3.60 Million |
|
LUPAKA GOLD CORP.
F:LQPA
|
$3.60 Million |
|
AFRIQUIA GAZ
BC:AFRIQUIA-GAZ
|
$3.60 Million |
|
Direct Communication Solutions Inc
PINK:DCSX
|
$3.59 Million |
|
Solaer Israel Ltd
TA:SOLR
|
$3.59 Million |
|
Perrot Duval Holding SA
SW:PEDU
|
$3.59 Million |
|
AuQ Gold Mining Inc
PINK:NSVLF
|
$3.59 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AYR WELLNESS INC.RES.VTG.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares AYR WELLNESS INC.RES.VTG.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently AYR WELLNESS INC.RES.VTG. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares AYR WELLNESS INC.RES.VTG.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AYR WELLNESS INC.RES.VTG. (3KJB) | €- | N/A | N/A | $3.60 Million |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |